SCHEMBL6918282

SCHEMBL6918282

CCc1nn(C)c(O)c1C(=O)c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
APP P05067 1/20 0.41
GAA P10253 1/20 0.41
HCAR3 P49019 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
HTT P42858 2/20 0.41
MAPT P10636 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
F7 P08709 1/20 0.41
F3 P13726 1/20 0.41
SARM1 Q6SZW1 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT6 Q8N6T7 1/20 0.41
SIRT1 Q96EB6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2214214 0.90 ALDH1A1 (0.43) ALDH1A1APPGAAHCAR3HCAR2
SCHEMBL6919835 0.88 L3MBTL1 (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2GAA
SCHEMBL6820177 0.86 ALDH1A1 (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2APP
SCHEMBL6921905 0.86 LMNA (0.41) ALDH1A1RAB9AAPPGAAHCAR3
SCHEMBL6922174 0.85 MAPT (0.43) ALDH1A1NPC1RAB9ASMN1; SMN2APP
SCHEMBL6920087 0.85 LMNA (0.47) ALDH1A1NPC1RAB9ASMN1; SMN2APP
SCHEMBL6921251 0.82 TSHR (0.49) ALDH1A1SMN1; SMN2APPGAAHCAR3
SCHEMBL6919778 0.78 ALDH1A1 (0.41) ALDH1A1APPGAAHCAR3HCAR2
SCHEMBL6920743 0.78 NPC1 (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2APP
SCHEMBL6916106 0.77 LMNA (0.46) ALDH1A1SMN1; SMN2APPGAAHCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004033431-A2 HYDROXYPYRAZOLES FOR USE AGAINST METABOLIC-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2004-04-22 WO claimed
WO-2004033431-A2 HYDROXYPYRAZOLES FOR USE AGAINST METABOLIC-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2004-04-22 WO disclosed